AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureInformation ScienceNamed GroupsHealth CareGeographicals
Anti-HIV AgentsAntiretroviral Therapy, Highly ActiveHIV InfectionsAnti-Retroviral AgentsHIV-1Drug Resistance, ViralCD4 Lymphocyte CountReverse Transcriptase InhibitorsViral LoadHIV Protease InhibitorsBenzoxazinesZidovudineDrug Resistance, Multiple, ViralNevirapineHIVDrug Therapy, CombinationInfectious Disease Transmission, VerticalAcquired Immunodeficiency SyndromeDrug TherapyLopinavirIndinavirRitonavirStavudineHIV Reverse TranscriptaseOrganophosphonatesLamivudineHIV Fusion InhibitorsNelfinavirPregnancy Complications, InfectiousHIV ProteaseRNA, ViralPyrimidinonesAdenineMedication AdherenceSouth AfricaIntegrase InhibitorsTreatment FailureDidanosineAIDS-Related Opportunistic InfectionsHIV-Associated Lipodystrophy SyndromeUgandaPatient ComplianceCohort StudiesSaquinavirTreatment OutcomeDrug MonitoringHIV SeropositivityViremiaGenotypeHIV Integrase InhibitorsDideoxynucleosidesVirus ReplicationDrug Interactionspol Gene Products, Human Immunodeficiency VirusAfrica South of the SaharaMutationCD4-Positive T-LymphocytesOxazinesHIV Wasting SyndromeDrugs, GenericCyclohexanesDrug Administration ScheduleZimbabwePregnancyMalawiTime FactorsRetrospective StudiesDeveloping CountriesProspective StudiesCommission on Professional and Hospital ActivitiesGenes, polRisk FactorsPyrrolidinonesAntiviral AgentsLipodystrophyPlasmaZalcitabineProtease InhibitorsCross-Sectional StudiesFollow-Up StudiesDrugs, InvestigationalAntitubercular AgentsPrevalenceInfant, NewbornDrug CombinationsClinical Trials as TopicGenitalia, FemaleLongitudinal StudiesImmune Reconstitution Inflammatory SyndromeHIV Envelope Protein gp41TuberculosisBotswanaGene Products, polLost to Follow-UpReceptors, CCR5PyridinesBrazilAIDS Dementia ComplexHIV SeronegativityDisease Progression